DRW Securities’s iShares US Pharmaceuticals ETF IHE Stock Holding History

DRW Securities’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,422	Closed	-$568K	–	164
2020 Q3	$568K	Hold	10,422	–	–	0.03%	91
2020 Q2	$535K	Hold	10,422	–	–	0.03%	119
2020 Q1	$468K	Hold	10,422	–	–	0.02%	159
2019 Q4	$556K	Hold	10,422	–	–	0.02%	113
2019 Q3	$486K	Sell	10,422 -1,500	-13%	-$71.8K	0.03%	97
2019 Q2	$599K	Buy	+11,922	New	+$589K	0.03%	66
2014 Q1	–	Sell	-69,654	Closed	-$2.74M	–	177
2013 Q4	$2.74M	Buy	+69,654	New	+$2.61M	0.12%	34

Other funds holding IHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

DRW Securities's IHE Position: Q4 2020 in Review

DRW Securities sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2020, closing a stake of 10,422 shares — an estimated $568K sold.

DRW Securities first reported a position in IHE in Q4 2013 and held it in 7 quarters. The position peaked at $2.74M in Q4 2013. 99 funds tracked by Wall St. Rank hold IHE as of Q4 2020.

DRW Securities reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2020 after selling out during the quarter.
DRW Securities sold 10,422 iShares US Pharmaceuticals ETF shares in Q4 2020, an estimated $568K.
DRW Securities first reported a position in iShares US Pharmaceuticals ETF in Q4 2013 and held it in 7 quarters.
DRW Securities's iShares US Pharmaceuticals ETF position peaked at $2.74M in Q4 2013.
99 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2020.

Based on DRW Securities's 13F filing for Q4 2020, filed 9 Feb 2021.